90 related articles for article (PubMed ID: 11682238)
1. Immunochemical control of the species origin of porcine crude heparin and detection of ovine and caprine materials.
Levieux A; Rivera V; Levieux D
J Pharm Biomed Anal; 2002 Jan; 27(1-2):305-13. PubMed ID: 11682238
[TBL] [Abstract][Full Text] [Related]
2. Immunochemical characterisation of species-specific antigens in bovine crude heparin.
Rivera V; Levieux A; Levieux D
J Pharm Biomed Anal; 2002 Jul; 29(3):431-41. PubMed ID: 12062644
[TBL] [Abstract][Full Text] [Related]
3. A sensitive ELISA for the detection of bovine crude heparin in porcine heparin.
Levieux A; Rivera V; Levieux D
J Immunoassay Immunochem; 2001; 22(4):323-36. PubMed ID: 11816801
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of Ag1, the major species-specific contaminant of bovine crude heparin, and its identification as an aprotinin/heparin complex.
Rivera V; Levieux A; Levieux D
J Pharm Biomed Anal; 2002 Jul; 29(3):443-58. PubMed ID: 12062645
[TBL] [Abstract][Full Text] [Related]
5. Species-specific identification of ruminant components contaminating industrial crude porcine heparin using real-time fluorescent qualitative and quantitative PCR.
Huang Q; Xu T; Wang GY; Huang JF; Xia H; Yin R; Tang A; Fu WL
Anal Bioanal Chem; 2012 Feb; 402(4):1625-34. PubMed ID: 22147273
[TBL] [Abstract][Full Text] [Related]
6. Immunochemical control of the species origin of intestinal mucosa used for heparin purification.
Levieux D; Levieux A
J Immunoassay Immunochem; 2001; 22(2):127-45. PubMed ID: 11486811
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of bovine from porcine gelatines using polyclonal anti-peptide antibodies in indirect and competitive indirect ELISA.
Venien A; Levieux D
J Pharm Biomed Anal; 2005 Sep; 39(3-4):418-24. PubMed ID: 15899572
[TBL] [Abstract][Full Text] [Related]
8. Chemometric analysis of porcine, bovine and ovine heparins.
Ouyang Y; Han X; Yu Y; Chen J; Fu L; Zhang F; Linhardt RJ; Fareed J; Hoppensteadt D; Jeske W; Kouta A; Zhang Z; Xia K
J Pharm Biomed Anal; 2019 Feb; 164():345-352. PubMed ID: 30428408
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of gelatins using polyclonal antibodies raised against tyrosylated bovine and porcine gelatins.
Venien A; Levieux D
J Immunoassay Immunochem; 2005; 26(3):215-29. PubMed ID: 16011147
[TBL] [Abstract][Full Text] [Related]
10. Highly sensitive real-time PCR method to identify species origin in heparinoids.
Pecorini S; Camurri G; Torrini L; Ferraresi R
Anal Bioanal Chem; 2020 Jan; 412(2):289-298. PubMed ID: 31802177
[TBL] [Abstract][Full Text] [Related]
11. A quantitative PCR method to quantify ruminant DNA in porcine crude heparin.
Concannon SP; Wimberley PB; Workman WE
Anal Bioanal Chem; 2011 Jan; 399(2):757-62. PubMed ID: 21058016
[TBL] [Abstract][Full Text] [Related]
12. Potency Adjusted Blended Heparin of Bovine, Ovine, and Porcine Heparin Exhibit Comparable Biologic Effects to Referenced Single-Sourced Porcine Heparin.
Olson G; Jeske W; Iqbal O; Krupa E; Farooqui A; Siddiqui F; Hoppensteadt D; Kouta A; Fareed J
Clin Appl Thromb Hemost; 2023; 29():10760296231163251. PubMed ID: 36908199
[No Abstract] [Full Text] [Related]
13. Comparative Pharmacological Profiles of Various Bovine, Ovine, and Porcine Heparins.
Kouta A; Jeske W; Hoppensteadt D; Iqbal O; Yao Y; Fareed J
Clin Appl Thromb Hemost; 2019; 25():1076029619889406. PubMed ID: 31793333
[TBL] [Abstract][Full Text] [Related]
14. Studies on Tissue Factor Pathway Inhibitor Antigen Release by Bovine, Ovine and Porcine Heparins Following Intravenous Administration to Non-Human Primates.
Kouta A; Hoppensteadt D; Bontekoe E; Jeske W; Duff R; Cera L; Fareed J
Clin Appl Thromb Hemost; 2020; 26():1076029620951851. PubMed ID: 33034200
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a competitive ELISA kit for the serological diagnosis of ovine, caprine and bovine brucellosis.
Portanti O; Tittarelli M; Di Febo T; Luciani M; Mercante MT; Conte A; Lelli R
J Vet Med B Infect Dis Vet Public Health; 2006 Dec; 53(10):494-8. PubMed ID: 17123429
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Heparins Derived From Bovine Tissues and Comparison to Porcine Intestinal Heparins.
St Ange K; Onishi A; Fu L; Sun X; Lin L; Mori D; Zhang F; Dordick JS; Fareed J; Hoppensteadt D; Jeske W; Linhardt RJ
Clin Appl Thromb Hemost; 2016 Sep; 22(6):520-7. PubMed ID: 27084870
[TBL] [Abstract][Full Text] [Related]
17. Validation of quantitative polymerase chain reaction methodology for monitoring DNA as a surrogate marker for species material contamination in porcine heparin.
Auguste C; Dereux S; Rousset M; Anger P
Anal Bioanal Chem; 2012 Jul; 404(1):43-50. PubMed ID: 22648164
[TBL] [Abstract][Full Text] [Related]
18. Authentication of animal origin of heparin and low molecular weight heparin including ovine, porcine and bovine species using 1D NMR spectroscopy and chemometric tools.
Monakhova YB; Diehl BWK; Fareed J
J Pharm Biomed Anal; 2018 Feb; 149():114-119. PubMed ID: 29112899
[TBL] [Abstract][Full Text] [Related]
19. A quantitative mass spectrometry method to differentiate bovine and ovine heparins from pharmaceutical porcine heparin.
Zhang B; Shi D; Li M; Shi F; Chi L
Carbohydr Polym; 2023 Feb; 301(Pt A):120303. PubMed ID: 36436866
[TBL] [Abstract][Full Text] [Related]
20. Preparation of low molecular weight heparins from bovine and ovine heparins using nitrous acid degradation.
Xie S; Guan Y; Zhu P; Li F; Yu M; Linhardt RJ; Chi L; Jin L
Carbohydr Polym; 2018 Oct; 197():83-91. PubMed ID: 30007661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
